The pain of peripheral diabetic neuropathy is relieved with Matrifen®

Matrifen® from Nycomed relieves the pain of peripheral diabetic neuropathy and other severe chronic pain and it has fewer adverse effects than other similar products.

Peripheral diabetic neuropathy
Matrifen® helps to relieve the pain of peripheral diabetic neuropathy along with other chronic illnesses.

>> More information on peripheral diabetic neuropathy and Matrifen®

Fewer adverse effects are seen when using Matrifen than when using other similar products. The Matrifen transdermal patch can be used for chronic pain in osteoarthritis patients, pheumatoid arthritis patients, patients with respiratory depression, hypoventilation and cognitive impairment.

Fentanyl belongs to the group of opioids, and transdermal fentanyl has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Treatment of chronic pain | Treatment of chronic non cancer pain | Transdermal fentanyl therapy